Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02783716 · ClinicalTrials.gov registry record · NA
Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02783716: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02783716 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02783716, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the role of blood vessel endothelial function in heart failure and the effect of Cardiac Resynchronization Therapy (CRT) on heart and endothelial function.
Interventions
- PROCEDURE Subcutaneous adipose tissue collection
- DIAGNOSTIC_TEST Peripheral arterial tonometry (PAT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-05 |
| Est. Completion | 2021-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02783716
The ClinicalTrials.gov registry entry for NCT02783716 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Subcutaneous adipose tissue collection is the first listed.
NCT02783716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02783716 about?
NCT02783716 is a clinical study titled "Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure". The purpose of this research study is to determine the role of blood vessel endothelial function in heart failure and the effect of Cardiac Resynchronization Therapy (CRT) on heart and endothelial function.
What is the current status of trial NCT02783716?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2016-05. Estimated completion is 2021-07-20.
What interventions are being tested in trial NCT02783716?
The interventions under investigation include: Subcutaneous adipose tissue collection (PROCEDURE), Peripheral arterial tonometry (PAT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02783716?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.